Items | lower tHcy group (<12.46μmol/L) | higher tHcy group (≥12.46μmol/L) | P value |
---|---|---|---|
Number | 113 | 114 | Â |
Sex, male | 61 (54.0%) | 72 (63.2%) | 0.161 |
Age, years | 66.90 ± 8.69 | 67.30 ± 10.04 | 0.751 |
Body Mass Index, kg/m2 | 23.42 (22.22, 24.87) | 23.52 (22.37, 25.95) | 0.189 |
Hypertension | 107 (94.7%) | 100 (87.7%) | 0.064 |
SBP, mmHg | 152.04 ± 20.45 | 152.32 ± 20.23 | 0.920 |
DBP, mmHg | 85.08 ± 10.31 | 83.74 ± 10.97 | 0.343 |
Diabetes | 75 (66.4%) | 69 (60.5%) | 0.361 |
FPG, mmol/L | 6.17 (5.29, 8.66) | 5.98 (5.31, 8.81) | 0.724 |
HbA1c, % | 6.90 (6.00, 8.85) | 6.55 (5.90, 8.90) | 0.564 |
Ischemic stroke or | |||
TIA history | 24 (21.2%) | 27 (23.7%) | 0.659 |
Coronary heart disease | 5 (4.4%) | 10 (8.8%) | 0.187 |
Current smoking | 33 (29.2%) | 50 (43.9%) | 0.022* |
Alcohol use | 18 (15.9%) | 19 (16.7%) | 0.880 |
Hyperlipidemia | 40 (35.7%) | 36 (31.6%) | 0.511 |
Total cholesterol, mmol/L | 4.39 ± 1.15 | 4.40 ± 0.89 | 0.972 |
Triglyceride, mmol/L | 1.48 (1.07, 2.28) | 1.57 (1.13, 2.00) | 0.995 |
HDL-C, mmol/L | 1.04 (0.88, 1.24) | 1.01 (0.85, 1.19) | 0.251 |
LDL-C, mmol/L | 2.42 ± 0.85 | 2.50 ± 0.68 | 0.453 |
Hemoglobin, g/L | 137.00 (127.50, 149.00) | 139.50 (129.75, 147.25) | 0.508 |
Fibrinogen, g/L | 2.96 (2.49, 3.41) | 2.85 (2.38, 3.44) | 0.472 |
CCrE, mL/(min*1.73m2) | 88.87 (71.30, 101.51) | 80.48 (63.06, 101.52) | 0.116 |
Uric acid, μmol/L | 284.00 (234.45, 337.25) | 308.10 (262.78, 374.00) | 0.013* |
NIHSS at baseline | 3 (2, 5) | 3 (2, 5) | 0.790 |
NIHSS at discharge | 3 (2, 5) | 3 (2, 5) | 0.823 |
IPI classification | Â | Â | 0.129 |
 PPI | 76 (67.3%) | 87 (76.3%) |  |
 SDPI | 37 (32.7%) | 27 (23.7%) |  |
Moderate to severe WMH | 48 (42.5%) | 43 (37.7%) | 0.464 |
Lacunes | 61 (54.0%) | 66 (57.9%) | 0.553 |
CSO-EPVS grade | Â | Â | 0.261 |
0 | 5 (4.4%) | 1 (0.9%) | Â |
1 | 52 (46.0%) | 46 (40.4%) | Â |
2 | 36 (31.9%) | 38 (33.3%) | Â |
3 | 13 (11.5%) | 22 (19.3%) | Â |
4 | 7 (6.2%) | 7 (6.1%) | Â |
Moderate to severe | Â | Â | Â |
CSO-EPVS | 56 (49.6%) | 67 (58.7%) | 0.164 |
BG-EPVS grade | |||
0 | 1 (0.9%) | 0 (0.0%) | <0.001* |
1 | 82 (72.6%) | 52 (45.6%) | Â |
2 | 25 (22.1%) | 37 (32.5%) | Â |
3 | 4 (3.5%) | 24 (21.0%) | Â |
4 | 1 (0.9%) | 1 (0.9%) | Â |
Moderate to severe | |||
BG-EPVS | 30 (26.5%) | 62 (54.4%) | <0.001* |
Brainstem-EPVS | 24 (21.2%) | 67 (58.8%) | <0.001* |